Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

Funt SA, Patil S, Feldman DR, Motzer RJ, Bajorin DF, Sheinfeld J, Tickoo SK, Reuter VE, Bosl GJ.

J Clin Oncol. 2019 Sep 10;37(26):2329-2337. doi: 10.1200/JCO.18.01608. Epub 2019 Jun 24.

PMID:
31233353
2.

PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.

Reis H, Serrette R, Posada J, Lu V, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Iyer G, Funt SA, Teo MY, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA.

Am J Surg Pathol. 2019 Jul;43(7):920-927. doi: 10.1097/PAS.0000000000001264.

PMID:
31135485
3.

A New Twist to an Old Tale: Immunotherapy in Non-muscle-invasive Bladder Cancer.

Funt SA, Pietzak EJ, Bajorin DF.

Eur Urol Oncol. 2018 Aug;1(3):199-201. doi: 10.1016/j.euo.2018.07.001. Epub 2018 Jul 24. No abstract available.

PMID:
31102621
4.

A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor.

Leiserson MDM, Syrgkanis V, Gilson A, Dudik M, Gillett S, Chayes J, Borgs C, Bajorin DF, Rosenberg JE, Funt S, Snyder A, Mackey L.

PLoS One. 2018 Dec 31;13(12):e0208422. doi: 10.1371/journal.pone.0208422. eCollection 2018.

5.

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

Pietzak EJ, Zabor EC, Bagrodia A, Armenia J, Hu W, Zehir A, Funt S, Audenet F, Barron D, Maamouri N, Li Q, Teo MY, Arcila ME, Berger MF, Schultz N, Dalbagni G, Herr HW, Bajorin DF, Rosenberg JE, Al-Ahmadie H, Bochner BH, Solit DB, Iyer G.

Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.

PMID:
30290956
6.

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

van Dijk N, Funt SA, Blank CU, Powles T, Rosenberg JE, van der Heijden MS.

Eur Urol. 2019 Mar;75(3):435-444. doi: 10.1016/j.eururo.2018.09.022. Epub 2018 Sep 28. Review.

PMID:
30274701
7.

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes.

Solovyov A, Vabret N, Arora KS, Snyder A, Funt SA, Bajorin DF, Rosenberg JE, Bhardwaj N, Ting DT, Greenbaum BD.

Cell Rep. 2018 Apr 10;23(2):512-521. doi: 10.1016/j.celrep.2018.03.042.

8.

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Teo MY, Seier K, Ostrovnaya I, Regazzi AM, Kania BE, Moran MM, Cipolla CK, Bluth MJ, Chaim J, Al-Ahmadie H, Snyder A, Carlo MI, Solit DB, Berger MF, Funt S, Wolchok JD, Iyer G, Bajorin DF, Callahan MK, Rosenberg JE.

J Clin Oncol. 2018 Jun 10;36(17):1685-1694. doi: 10.1200/JCO.2017.75.7740. Epub 2018 Feb 28.

9.

Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out.

van de Wetering RAW, Sleijfer S, Feldman DR, Funt SA, Bosl GJ, de Wit R.

J Clin Oncol. 2018 Mar 20;36(9):837-840. doi: 10.1200/JCO.2017.76.5610. Epub 2018 Feb 1. No abstract available.

PMID:
29389229
10.

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma.

Pianko MJ, Funt SA, Page DB, Cattry D, Scott EC, Ansell SM, Borrello IM, Gutierrez M, Lendvai N, Hassoun H, Landgren CO, Lesokhin AM.

Leuk Lymphoma. 2018 Jan;59(1):221-224. doi: 10.1080/10428194.2017.1320713. Epub 2017 May 30. No abstract available.

11.

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.

Snyder A, Nathanson T, Funt SA, Ahuja A, Buros Novik J, Hellmann MD, Chang E, Aksoy BA, Al-Ahmadie H, Yusko E, Vignali M, Benzeno S, Boyd M, Moran M, Iyer G, Robins HS, Mardis ER, Merghoub T, Hammerbacher J, Rosenberg JE, Bajorin DF.

PLoS Med. 2017 May 26;14(5):e1002309. doi: 10.1371/journal.pmed.1002309. eCollection 2017 May.

12.

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.

Funt SA, Rosenberg JE.

Nat Rev Clin Oncol. 2017 Apr;14(4):221-234. doi: 10.1038/nrclinonc.2016.188. Epub 2016 Nov 22. Review.

13.

The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach.

Funt SA, Feldman DR, Bosl GJ.

Oncology (Williston Park). 2016 Jul;30(7):653-64. Review.

14.

The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.

Funt SA, Chapman PB.

Clin Cancer Res. 2016 May 15;22(10):2323-8. doi: 10.1158/1078-0432.CCR-15-1961. Epub 2016 Feb 3. Review.

15.

Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.

Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR, Kirabo A, Xiao L, Chen W, Itani HA, Michell D, Huan T, Zhang Y, Takaki S, Titze J, Levy D, Harrison DG, Madhur MS.

J Clin Invest. 2015 Mar 2;125(3):1189-202. doi: 10.1172/JCI76327. Epub 2015 Feb 9.

16.

CTLA-4 antibodies: new directions, new combinations.

Funt SA, Page DB, Wolchok JD, Postow MA.

Oncology (Williston Park). 2014 Nov;28 Suppl 3:6-14. Review.

17.

Pegylation of high-density lipoprotein decreases plasma clearance and enhances antiatherogenic activity.

Murphy AJ, Funt S, Gorman D, Tall AR, Wang N.

Circ Res. 2013 Jun 21;113(1):e1-e9. doi: 10.1161/CIRCRESAHA.113.301112. Epub 2013 Apr 23.

18.

Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.

Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1565-72. doi: 10.1161/ATVBAHA.111.227629. Epub 2011 Apr 7.

19.

Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation.

Goldstone AB, Chikwe J, Pinney SP, Anyanwu AC, Funt SA, Polanco A, Adams DH.

Am J Cardiol. 2011 Mar 1;107(5):755-60. doi: 10.1016/j.amjcard.2010.10.057.

PMID:
21316508
20.

A right atrial mass, patent foramen ovale, and indwelling central venous catheter in a patient with a malignancy: a diagnostic and therapeutic dilemma.

Funt S, Lerakis S, McLean DS, Willis P, Book W, Martin RP.

J Am Soc Echocardiogr. 2010 Apr;23(4):457.e1-3. doi: 10.1016/j.echo.2009.09.006. Epub 2009 Oct 30.

PMID:
19879732
21.

Primary pineal and meningeal malignant melanomatosis.

Mitchell PJ, Funt SA, Gonzales MF, Popovic EA.

J Clin Neurosci. 1998 Jul;5(3):353-6.

PMID:
18639049
22.
23.

A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.

Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D.

Mol Psychiatry. 2006 Sep;11(9):858-66. Epub 2006 Jun 13.

PMID:
16770335
24.

Role of CT in the management of recurrent ovarian cancer.

Funt SA, Hricak H, Abu-Rustum N, Mazumdar M, Felderman H, Chi DS.

AJR Am J Roentgenol. 2004 Feb;182(2):393-8.

PMID:
14736669
25.

Ovarian malignancies.

Funt SA, Hricak H.

Top Magn Reson Imaging. 2003 Aug;14(4):329-37. Review.

PMID:
14578777
26.

Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer.

Eberhardt SC, Choi PH, Bach AM, Funt SA, Felderman HE, Hann LE.

J Ultrasound Med. 2003 Apr;22(4):335-43; quiz 345-6.

PMID:
12693617
27.

Subcutaneous nodules at the injection site of low-molecular-weight heparin: a mimic of metastatic disease at CT.

Funt SA, Hidalgo A, Panicek DM.

J Comput Assist Tomogr. 2002 Jul-Aug;26(4):520-3.

PMID:
12218812
28.

Detection and characterization of adnexal masses.

Funt SA, Hann LE.

Radiol Clin North Am. 2002 May;40(3):591-608. Review.

PMID:
12117195
29.

Environmentally conscious film masking system for mammography.

Funt SA, Samii M, Leitman BS.

AJR Am J Roentgenol. 1998 May;170(5):1398. No abstract available.

PMID:
9574627
30.

Clinical image. MR demonstration of submucosal fat in a patient with Crohn's disease.

Funt SA, Krinsky G, Horowitz L.

J Comput Assist Tomogr. 1996 Nov-Dec;20(6):940-1. Review. No abstract available.

PMID:
8933795
31.

Hemoptysis: CT-bronchoscopic correlations in 58 cases.

Naidich DP, Funt S, Ettenger NA, Arranda C.

Radiology. 1990 Nov;177(2):357-62.

PMID:
2217769

Supplemental Content

Support Center